The model features (Table 6) consisted of three assays: CCL2 down-regulation in a complex coculture of peripheral blood mononuclear cells and endothelial cells, CD40 down-regulation in the same system, and a cell viability assay in the HepG2 human hepatocellular carcinoma cell line. The gene discussed is CCL2; the disease is hepatocellular carcinoma.